HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.

AbstractBACKGROUND:
Glycogen storage disease II is characterized by a deficiency of the lysosomal enzyme acid alpha-glucosidase. Currently, glycogen storage disease II is diagnosed by demonstrating the virtual absence or a marked reduction of acid alpha-glucosidase activity in muscle biopsies, cultured fibroblasts, or purified lymphocytes. Early diagnosis and treatment of glycogen storage disease II are considered to be critical for maximum efficacy of the enzyme replacement therapies that are in development. However, these existing diagnostic methods are not suited for newborn screening. We developed an assay useful for newborn screening for glycogen storage disease II.
METHODS:
A series of three enzyme assays to measure the alpha-glucosidase activities in dried blood spots on filter paper was developed. The measurement of acid alpha-glucosidase activity with minimal interference by other alpha-glucosidases was accomplished using maltose as an inhibitor. The method was used on samples from glycogen storage disease II patients, obligate heterozygotes, and healthy controls.
RESULTS:
Glycogen storage disease II patients were distinguished from carriers and healthy controls using the series of enzyme assays.
CONCLUSIONS:
We developed a simple and noninvasive screening method for glycogen storage disease II. The method could be incorporated into newborn screening.
AuthorsNéstor A Chamoles, Gabriela Niizawa, Mariana Blanco, Daniela Gaggioli, Carina Casentini
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 347 Issue 1-2 Pg. 97-102 (Sep 2004) ISSN: 0009-8981 [Print] Netherlands
PMID15313146 (Publication Type: Journal Article)
Chemical References
  • Buffers
  • Glycoside Hydrolase Inhibitors
  • Indicators and Reagents
  • Maltose
  • Glucan 1,4-alpha-Glucosidase
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Buffers
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Filtration
  • Glucan 1,4-alpha-Glucosidase (antagonists & inhibitors)
  • Glycogen Storage Disease Type II (blood, diagnosis, enzymology)
  • Glycoside Hydrolase Inhibitors
  • Humans
  • Hydrogen-Ion Concentration
  • Indicators and Reagents
  • Infant
  • Infant, Newborn
  • Male
  • Maltose (chemistry, pharmacology)
  • Middle Aged
  • Neonatal Screening
  • Paper
  • Specimen Handling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: